{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T20:31:46Z","timestamp":1768941106265,"version":"3.49.0"},"reference-count":29,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/mmr.2017.7111","type":"journal-article","created":{"date-parts":[[2017,7,28]],"date-time":"2017-07-28T06:54:48Z","timestamp":1501224888000},"page":"3974-3982","source":"Crossref","is-referenced-by-count":12,"title":["Anti-CD20 monoclonal antibody combined with adenovirus vector-mediated IL-10 regulates spleen CD4+\/CD8+ T cells and T-bet\/GATA-3 expression in NOD mice"],"prefix":"10.3892","volume":"16","author":[{"given":"Aiping","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,7,28]]},"reference":[{"key":"key20180108002920_b1-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"key20180108002920_b2-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1053\/ajkd.2003.50078","article-title":"Reduction of Endpoints in NIDDM with the Angiotensin II Receptor Antagonist Losartan study: Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study","volume":"41","author":"Keane","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key20180108002920_b3-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2337\/diabetes.54.1.92","article-title":"Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes","volume":"54","author":"Lindley","year":"2005","journal-title":"Diabetes"},{"key":"key20180108002920_b4-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"key":"key20180108002920_b5-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/jcb.10347","article-title":"Vitamin D and autoimmune diabetes","volume":"88","author":"Zella","year":"2003","journal-title":"J Cell Biochem"},{"key":"key20180108002920_b6-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1103336","article-title":"T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3","volume":"307","author":"Hwang","year":"2005","journal-title":"Science"},{"key":"key20180108002920_b7-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0167-5699(00)01712-6","article-title":"Transcriptional regulation of Th1\/Th2 polarization","volume":"21","author":"Rengarajan","year":"2000","journal-title":"Immunol Today"},{"key":"key20180108002920_b8-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10875-005-4092-4","article-title":"mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: Link with disease activity","volume":"25","author":"Kawashima","year":"2005","journal-title":"J Clin Immunol"},{"key":"key20180108002920_b9-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11892-014-0543-8","article-title":"Role of B lymphocytes in the pathogenesis of type 1 diabetes","volume":"14","author":"Hinman","year":"2014","journal-title":"Curr Diab Rep"},{"key":"key20180108002920_b10-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1172\/JCI34236","article-title":"B cell depletion: A novel therapy for autoimmune diabetes?","volume":"117","author":"Bour-Jordan","year":"2007","journal-title":"J Clin Invest"},{"key":"key20180108002920_b11-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/dc15-1765","article-title":"Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults","volume":"39","author":"Deng","year":"2016","journal-title":"Diabetes Care"},{"key":"key20180108002920_b12-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1172\/JCI32405","article-title":"Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice","volume":"117","author":"Hu","year":"2007","journal-title":"J Clin Invest"},{"key":"key20180108002920_b13-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.2337\/diabetes.53.10.2581","article-title":"Investigation of the role of B-cells in type 1 diabetes in the NOD mouse","volume":"53","author":"Wong","year":"2004","journal-title":"Diabetes"},{"key":"key20180108002920_b14-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"key20180108002920_b15-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/ibd.20215","article-title":"Exacerbation of ulcerative colitis after rituximab salvage therapy","volume":"13","author":"Goetz","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"key20180108002920_b16-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1038\/sj.onc.1207336","article-title":"Rituximab inhibits p38 MAPK activity in 2F7 B NHL and decreases IL-10 transcription: Pivotal role of p38 MAPK in drug resistance","volume":"23","author":"Vega","year":"2004","journal-title":"Oncogene"},{"key":"key20180108002920_b17-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diabetes.52.3.708","article-title":"Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice","volume":"52","author":"Zhang","year":"2003","journal-title":"Diabetes"},{"key":"key20180108002920_b18-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/dmrr.2780","article-title":"Vaccination with a co-expression DNA plasmid containing a GAD65 gene fragment and the IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes","volume":"32","author":"Liu","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"key20180108002920_b19-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11010-010-0539-x","article-title":"Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine","volume":"344","author":"Xu","year":"2010","journal-title":"Mol Cell Biochem"},{"key":"key20180108002920_b20-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/db13-1639","article-title":"Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens","volume":"64","author":"Kleffel","year":"2015","journal-title":"Diabetes"},{"key":"key20180108002920_b21-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20180108002920_b22-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.4049\/jimmunol.0802501","article-title":"Requirement of B cells for generating CD4+ T cell memory","volume":"182","author":"Whitmire","year":"2009","journal-title":"J Immunol"},{"key":"key20180108002920_b23-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.4049\/jimmunol.1103055","article-title":"The dual effects of B cell depletion on antigen-specific T cells in BDC2.5NOD mice","volume":"188","author":"Xiang","year":"2012","journal-title":"J Immunol"},{"key":"key20180108002920_b24-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.2337\/db12-1175","article-title":"Combination treatment with anti-CD20 and oral anti-CD3 prevents and reverses autoimmune diabetes","volume":"62","author":"Hu","year":"2013","journal-title":"Diabetes"},{"key":"key20180108002920_b25-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2353\/ajpath.2006.060539","article-title":"In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: Studies from an acute model","volume":"169","author":"Calderon","year":"2006","journal-title":"Am J Pathol"},{"key":"key20180108002920_b26-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.2337\/diabetes.54.suppl_2.S97","article-title":"Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities","volume":"54","author":"Cnop","year":"2005","journal-title":"Diabetes"},{"key":"key20180108002920_b27-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00439-004-1146-2","article-title":"Identification of a novel type 1 diabetes susceptibility gene, T-bet","volume":"115","author":"Sasaki","year":"2004","journal-title":"Hum Genet"},{"key":"key20180108002920_b28-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20180108002920_b29-mmr-16-04-3974","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clim.2007.07.019","article-title":"Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice","volume":"126","author":"Asari","year":"2008","journal-title":"Clin Immunol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T01:09:56Z","timestamp":1515373796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2017.7111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,28]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,7,28]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/mmr.2017.7111"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2017.7111","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,28]]}}}